Moreover, the genetic approach has demonstrated that the effect of the AMPK inhibition by compound C was lost in AMPK α2 knockout mice during stroke, which confirmed AMPK-specific action of compound C [14], [37]. The gene discussed is PRKAA1; the disease is Stroke.